- Release Date: 24/10/24 08:25
- Summary: FDA accepts NDA and grants priority review for Pixclara
- Price Sensitive: Yes
- Download Document 148.42KB
- Forums
- ASX - By Stock
- TLX
- Ann: FDA accepts NDA and grants priority review for Pixclara
TLX
telix pharmaceuticals limited
Add to My Watchlist
2.70%
!
$17.13

Ann: FDA accepts NDA and grants priority review for Pixclara
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$17.13 |
Change
0.450(2.70%) |
Mkt cap ! $5.779B |
Open | High | Low | Value | Volume |
$16.50 | $17.23 | $16.36 | $46.59M | 2.776M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 635 | $17.13 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$17.18 | 737 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
7 | 3346 | 17.130 |
2 | 5820 | 17.120 |
2 | 3578 | 17.110 |
3 | 8694 | 17.100 |
4 | 3782 | 17.080 |
Price($) | Vol. | No. |
---|---|---|
17.140 | 13 | 1 |
17.180 | 737 | 1 |
17.190 | 469 | 1 |
17.200 | 3553 | 3 |
17.210 | 4000 | 1 |
Last trade - 16.13pm 13/08/2025 (20 minute delay) ? |
Featured News
TLX (ASX) Chart |